サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：がん免疫療法創薬アウトソーシングの世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測
市場調査レポート
商品コード
1175405

がん免疫療法創薬アウトソーシングの世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
出版日: | 発行: Value Market Research | ページ情報: 英文 250 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
がん免疫療法創薬アウトソーシングの世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測
出版日: 2022年12月01日
発行: Value Market Research
ページ情報: 英文 250 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Value Market Research社は、世界のがん免疫療法創薬アウトソーシング市場を深く調査し、今後数年間の業界の大きな成長を予見しています。世界のがん免疫療法創薬アウトソーシング市場レポートは、完全な産業分析、市場規模、市場シェア、成長動向、2023年から2028年までの予測を提供します。当レポートは、詳細な市場イントロダクションと、レポートの主な成長数値にハイライトを当てたエグゼクティブサマリーから始まります。続く章では、市場のバリューチェーン、ポーターのファイブフォースモデル、市場の魅力度分析について論じています。また、COVID-19の影響分析に関する独自の章を設け、市場がパンデミックにどのように対応してきたかを理解していきます。

本レポートの市場力学のセクションでは、現在の市場の促進要因・抑制要因、課題・リスク、今後の機会について詳しく説明しています。このセクションは、企業の戦略担当者や新製品開発部門にとって、非常に興味深い内容となっています。世界のがん免疫療法創薬アウトソーシング市場調査では、市場をセグメント化し、収益および/または売上高で市場規模を提供します。このデータは地域別、後に国別に細分化されています。データは、世界中の詳細な一次インタビューや業界専門家を通じて収集されています。詳細な調査手法は、サンプルレポートでご覧いただけます。これらの市場推定は、このがん免疫療法創薬アウトソーシング市場に影響を与える現在の市場力学とともに、最新の社会的、政治的、経済的変化にも影響を受けています。

がん免疫療法創薬アウトソーシング市場レポートの次のセクションでは、市場競争力を調査し、いくつかの主要な市場プレーヤー/メーカーのプロファイルを作成します。これらのセクションは、競合他社の製品ライン、財務、最近の市場開拓、業界トップシェアを誇る企業を理解するための情報が豊富です。

目次

第1章 序文

  • 当レポートの内容
    • 目的
    • 対象読者
    • ユニークセリング・プロポジション（USP）とオファリング
  • 調査範囲
  • 調査手法
    • 市場調査プロセス
    • 市場調査手法

第2章 エグゼクティブサマリー

  • がん免疫療法創薬アウトソーシング市場のハイライト
  • がん免疫療法創薬アウトソーシングの世界市場スナップショット

第3章 がん免疫療法創薬アウトソーシング-産業分析

  • イントロダクション
  • がん免疫療法創薬アウトソーシング市場の市場促進要因
  • がん免疫療法創薬アウトソーシング市場の市場抑制要因
  • がん免疫療法創薬アウトソーシングの市場機会
  • がん免疫療法創薬アウトソーシングの市場動向
  • がん免疫療法創薬アウトソーシング市場のポーターのファイブフォース分析
  • がん免疫療法創薬アウトソーシング市場の魅力度分析
    • 薬剤タイプ別市場魅力度分析
    • サービスタイプ別市場魅力度分析
    • がんタイプ別市場魅力度分析
    • 地域別市場魅力度分析

第4章 バリューチェーン分析

  • がん免疫療法創薬アウトソーシングバリューチェーン分析
  • がん免疫療法創薬アウトソーシングの原材料分析
    • 原材料のリスト
    • がん免疫療法創薬アウトソーシングの原材料メーカーリスト
    • がん免疫療法創薬アウトソーシング主要原材料の価格動向
  • 潜在的なバイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • 間接マーケティング
    • マーケティングチャネルの開発動向

第5章 がん免疫療法創薬アウトソーシングの世界市場分析：薬物タイプ別

  • 薬剤タイプ別概要
  • がん免疫療法創薬アウトソーシングの世界市場分析：薬剤タイプ別概要
  • モノクローナル抗体：地域別市場分析
  • 免疫調節薬：地域別市場分析
  • がん溶解性ウイルス治療薬とがんワクチン：地域別市場分析
  • その他：地域別市場分析

第6章 がん免疫療法創薬アウトソーシングの世界市場分析：サービスタイプ別

  • サービスタイプ別概要
  • がん免疫療法創薬アウトソーシングの世界市場分析：サービスタイプ別概要
  • ターゲット同定とバリデーション：地域別市場分析
  • リードのスクリーニングとキャラクタリゼーション：地域別市場分析
  • セルベースアッセイ：地域別市場分析

第7章：がん免疫療法創薬アウトソーシングの世界市場分析：がんタイプ別

  • がんタイプ別概要
  • 世界のがん免疫療法創薬アウトソーシング市場分析：がんタイプ別概要
  • 肺：地域別市場分析
  • 乳房：地域別市場分析
  • 大腸：地域別市場分析
  • 地域別メラノーマの市場分析
  • 地域別前立腺の市場分析
  • 地域別頭頸部の市場分析
  • 地域別卵巣の市場分析
  • 地域別膵臓の市場分析

第8章 がん免疫療法創薬アウトソーシングの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米
    • 概要
    • 北米のがん免疫療法創薬アウトソーシング市場推定値：国別
    • 米国
    • その他北米地域
  • 欧州
    • 概要
    • 欧州のがん免疫療法創薬アウトソーシング市場予測：市場セグメント別
    • 欧州のがん免疫療法創薬アウトソーシング市場推定値：国別
    • 英国
    • フランス
    • ドイツ
    • その他の欧州地域
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域のがん免疫療法創薬アウトソーシング市場予測：市場セグメント別
    • アジア太平洋地域のがん免疫療法創薬アウトソーシング市場推定値：国別
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • 概要
    • ラテンアメリカのがん免疫療法創薬アウトソーシング市場予測：市場セグメント別
    • ラテンアメリカのがん免疫療法創薬アウトソーシング市場推定値：国別
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ地域
    • 概要
    • 中東・アフリカのがん免疫療法創薬アウトソーシング市場予測：市場セグメント別
    • 中東・アフリカのがん免疫療法創薬アウトソーシング市場推定値：国別
    • 中東地域
    • アフリカ

第9章 がん免疫療法創薬アウトソーシング企業の競合情勢

  • がん免疫療法創薬アウトソーシング市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Aquila BioMedical
    • 企業概要
    • 製品紹介
    • 最近の開発状況
  • BPS Bioscience, Inc.
    • 会社概要
    • 製品紹介
    • 最近の開発状況
  • Celentyx Ltd.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Covance, Inc.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Crown Bioscience, Inc.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • DiscoverX Corporation
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Explicyte
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Genscript Biotech Corporation
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • HD Biosciences Co., Ltd.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Horizon Discovery Group PLC
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • ImmunXperts SA
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Molecular Imaging, Inc.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Personalis, Inc.
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Promega Corporation
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • STC Biologics
    • 会社概要
    • 製品情報
    • 最近の開発状況

第11章 COVID-19の発生による影響分析

  • COVID-19の発生が市場に与える影響分析
    • 生産への直接的な影響
    • サプライチェーンと市場の混乱
    • 企業および金融市場への財務的影響
  • COVID-19の生産、輸入、輸出、需要別の影響分析
  • COVID-19発生前後の市場推移
  • コロナウイルス（COVID-19）流行別2020年市場規模への影響予測：シナリオ別
  • COVID-19：市場に関するミクロおよびマクロ要因の分析

注：企業プロファイルにおいて、財務の詳細や最近の開発は、入手可能な場合、または非公開会社の場合、カバーされていない場合があります。

図表

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Monoclonal Antibodies by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Immunomodulators by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Oncolytic Viral Therapies And Cancer Vaccines by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Others by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Target Identification And Validation by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lead Screening And Characterization by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Cell Based Assays by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lung by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Breast by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Colorectal by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Melanoma by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Prostate by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Head And Neck by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Ovarian by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Pancreatic by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Geography (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • United State Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type(USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • France Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • China Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • India Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Rest of Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Service Type (USD MN)
  • Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Cancer Type (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis

LIST OF FIGURES

  • Research Scope of Cancer Immunotherapy Drug Discovery Outsourcing Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Service Type
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Monoclonal Antibodies by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Immunomodulators by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Oncolytic Viral Therapies And Cancer Vaccines by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Others by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Target Identification And Validation by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lead Screening And Characterization by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Cell Based Assays by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Lung by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Breast by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Colorectal by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Melanoma by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Prostate by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Head And Neck by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Ovarian by Geography (USD MN)
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis in Pancreatic by Geography (USD MN)
  • Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market by Revenue
  • Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market by Revenue
  • Recent Development in Cancer Immunotherapy Drug Discovery Outsourcing Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11211227

Value Market Research deeply researched the Global Cancer Immunotherapy Drug Discovery Outsourcing Market to foresee a significant growth in the industry over the upcoming years. The global cancer immunotherapy drug discovery outsourcing market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cancer immunotherapy drug discovery outsourcing market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cancer immunotherapy drug discovery outsourcing market.

The next sections of the cancer immunotherapy drug discovery outsourcing market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

  • North America: United States, Canada, and Mexico
  • Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
  • Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC
  • Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America
  • Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Drug Type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies And Cancer Vaccines
  • Others

By Service Type

  • Target Identification And Validation
  • Lead Screening And Characterization
  • Cell Based Assays

By Cancer Type

  • Lung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head And Neck
  • Ovarian
  • Pancreatic

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot

3 . CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.3. Market Restraints of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.4. Opportunities of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.5. Trends of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.6. Porter's Five Force Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market
  • 3.7. Cancer Immunotherapy Drug Discovery Outsourcing Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Drug Type
    • 3.7.2 Market Attractive Analysis by Service Type
    • 3.7.3 Market Attractive Analysis by Cancer Type
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Cancer Immunotherapy Drug Discovery Outsourcing Value Chain Analysis
  • 4.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Manufactures List
    • 4.2.3. Price Trend of Cancer Immunotherapy Drug Discovery Outsourcing Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE

  • 5.1 Overview by Drug Type
  • 5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type
  • 5.3 Market Analysis of Monoclonal Antibodies by Regions
  • 5.4 Market Analysis of Immunomodulators by Regions
  • 5.5 Market Analysis of Oncolytic Viral Therapies And Cancer Vaccines by Regions
  • 5.6 Market Analysis of Others by Regions

6 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE

  • 6.1 Overview by Service Type
  • 6.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type
  • 6.3 Market Analysis of Target Identification And Validation by Regions
  • 6.4 Market Analysis of Lead Screening And Characterization by Regions
  • 6.5 Market Analysis of Cell Based Assays by Regions

7 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE

  • 7.1 Overview by Cancer Type
  • 7.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type
  • 7.3 Market Analysis of Lung by Regions
  • 7.4 Market Analysis of Breast by Regions
  • 7.5 Market Analysis of Colorectal by Regions
  • 7.6 Market Analysis of Melanoma by Regions
  • 7.7 Market Analysis of Prostate by Regions
  • 7.8 Market Analysis of Head And Neck by Regions
  • 7.9 Market Analysis of Ovarian by Regions
  • 7.10. Market Analysis of Pancreatic by Regions

8 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.4.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.6.3. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES

  • 9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Aquila BioMedical
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. BPS Bioscience, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Celentyx Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Covance, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Crown Bioscience, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. DiscoverX Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Explicyte
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Genscript Biotech Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. HD Biosciences Co., Ltd.
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Horizon Discovery Group PLC
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. ImmunXperts SA
    • 10.13.1. Company Overview
    • 10.13.2. Financials
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. Molecular Imaging, Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financials
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Personalis, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financials
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. Promega Corporation
    • 10.16.1. Company Overview
    • 10.16.2. Financials
    • 10.16.3. Products
    • 10.16.4. Recent Developments
  • 10.17. STC Biologics
    • 10.17.1. Company Overview
    • 10.17.2. Financials
    • 10.17.3. Products
    • 10.17.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 11.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 11.1.1. Direct Impact on Production
    • 11.1.2. Supply Chain and Market Disruption
    • 11.1.3. Financial Impact on Firms and Financial Markets
  • 11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 11.3. Pre V/S Post COVID-19 Market
  • 11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 11.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies